Searched for
HALOL FACILITY
Organon gives Sun Pharma scale and reach, but challenge lies in integration, executionSun Pharma has acquired Organon & Co for $11.75 billion. This deal provides Sun Pharma with expanded global scale and commercial reach. It ...- Sun Pharma shares in focus after USFDA flags ‘official action indicated’ status for Halol facilitySun Pharma shares: The company revealed that the FDA classified its Halol facility as “Official Action Indicated” after finding CGMP violat...
- Sun Pharma shares in focus after US FDA issues eight observations for Halol facilitySun Pharma shares will be in focus after the US FDA issued eight observations for its Halol facility following a GMP inspection. The plant ...
- US FDA issues import alert on Sun Pharma's Halol facilitySun Pharma on Thursday said the US Food and Drug Administration (USFDA) has imposed an import alert on its Halol manufacturing site in Guja...
- US FDA lists Sun Pharma's Halol unit under 'import alert'The United States Food and Drug Administration (US FDA) has placed Sun Pharmaceuticals' Halol unit under 'import alert'. This implies that ...
- Sun Pharma drops 3% as USFDA initiates action against Halol facilityUSFDA inspected the facility from December 3 to December 13 and had issued eight observations, the company had earlier said in a regulatory...
- Sun Pharma gets 6 observations by USFDA for its Halol facility"At the conclusion of the inspection, the agency issued a Form 483, with six observations," it added.
- USFDA conducts inspection of Sun Pharma’s Halol site: SourcesThe USFDA inspection at Halol in 2015 had resulted in 23 observations – a set of deficiencies in the manufacturing processes.
- USFDA subjects SPARC Xelpros nod to 'satisfactory resolution'Earlier this month, Sun Pharma said the US health regulator had made nine observations after the completion of inspection of its Halol faci...
- USFDA report on Halol unit to be positive in long-term: SunThe company's Halol facility recently underwent an inspection by the US Food and Drug Administration (USFDA).
- Sun Pharma EPS may fall by up to 6% on USFDA notice on Halol plantThe US FDA issued the notice on Tuesday with nine inspectional observations after an onsite inspection of Sun Pharma’s Halol facility in Gu...
- USFDA’s notice may shave off 2-6% from Sun Pharma's EPS in FY18Analyst believes that Form 483 observations may delay the clearance of Halol facility and see full remediation only by first quarter of cal...
- USFDA made 9 observations post Halol unit inspection: Sun PharmaThe United States Food and Drug Administration (USFDA) inspected the Halol facility from November 17, 2016 through December 1, 2016, Sun Ph...
- Sun Pharma trades higher after falling 8% in past four sessionsSun Pharma on Wednesday said the US regulator had issued an observation letter after the completion of inspection of its Halol facility.
- FDA issues observations post Sun Pharma Halol plant inspectionThe approval of several of Sun's key drugs in the United States, the drugmaker's biggest market, depends on the clearance on its Halol plan...
- Sun Pharma shares set to extend losses for fourth day on rising concern over Halol facilityETNow on Tuesday reported that the USFDA has informed that the Halol facility has issued a 14-page Form 483 post inspection.
- For Sun Pharma, a lot rides on USFDA's report on Halol PlantThe Sun Pharma stock has appreciated 13% since the announcement of its second quarter performance on November 10.
- Sun Pharma to ask FDA in Q1 FY17 for Halol re-inspectionDrug major Sun Pharmaceutical Industries may ask the US health regulator in the first quarter of next fiscal for re-inspection of its Halol...
- Sun Pharma shares a good buy despite short-term painStock may see a sell-off on earnings downgrades & FDA warning, but co has not revised revenue guidance & FIs have steadily raised holdings.
- Sun Pharma gets warning letter from US FDA for its Halol siteSun Pharmaceutical Industries today said it has received a warning letter from the USFDA over violation of manufacturing norms in its facil...
Load More
